Cited by 281Alzheimer's disease research and treatmentsAutophagy in Disease and TherapyCellular transport and secretion

PICALM modulates autophagy activity and tau accumulation

Open access
Moreau, Kevin, Fleming, Angeleen, Imarisio, Sara, Lopez Ramirez, Ana, Mercer, Jacob L., Jimenez-Sanchez, Maria, Bento, Carla F., Puri, Claudia +7 more·2014·Nature Communications

Abstract

Genome-wide association studies have identified several loci associated with Alzheimer’s disease (AD), including proteins involved in endocytic trafficking such as PICALM/CALM (phosphatidylinositol binding clathrin assembly protein). It is unclear how these loci may contribute to AD pathology. Here we show that CALM modulates autophagy and alters clearance of tau, a protein which is a known autophagy substrate and which is causatively linked to AD, both in vitro and in vivo . Furthermore, altered CALM expression exacerbates tau-mediated toxicity in zebrafish transgenic models. CALM influences autophagy by regulating the endocytosis of SNAREs, such as VAMP2, VAMP3 and VAMP8, which have diverse effects on different stages of the autophagy pathway, from autophagosome formation to autophagosome degradation. This study suggests that the AD genetic risk factor CALM modulates autophagy, and this may affect disease in a number of ways including modulation of tau turnover.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ncomms5998

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 60

  1. Himmelstein D. S., Ward S. M., Lancia J. K., Patterson K. R. & Binder L. I. Tau as a therapeutic target in neurodegenerative disease. Pharmacol. Ther. 136, 8– 22 (2012). 22790092 PMC3697479
  2. Ravikumar B., Berger Z., Vacher C., O'Kane C. J. & Rubinsztein D. C. Rapamycin pre-treatment protects against apoptosis. Hum. Mol. Genet. 15, 1209– 1216 (2006). 16497721
  3. Nixon R. A. The role of autophagy in neurodegenerative disease. Nat. Med. 19, 983– 997 (2013). 23921753
  4. Harris H. & Rubinsztein D. C. Control of autophagy as a therapy for neurodegenerative disease. Nat. Rev. Neurol. 8, 108– 117 (2012). 22187000
  5. Pickford F. et al. The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J. Clin. Invest. 118, 2190– 2199 (2008). 18497889 PMC2391284
  6. Caccamo A., Majumder S., Richardson A., Strong R. & Oddo S. Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments. J. Biol. Chem. 285, 13107– 13120 (2010). 20178983 PMC2857107
  7. Xie Z. & Klionsky D. J. Autophagosome formation: core machinery and adaptations. Nat. Cell Biol. 9, 1102– 1109 (2007). 17909521
  8. Ravikumar B. et al. Regulation of mammalian autophagy in physiology and pathophysiology. Physiol. Rev. 90, 1383– 1435 (2010). 20959619
  9. Hailey D. W. et al. Mitochondria supply membranes for autophagosome biogenesis during starvation. Cell 141, 656– 667 (2010). 20478256 PMC3059894
  10. van der Vaart A., Griffith J. & Reggiori F. Exit from the Golgi is required for the expansion of the autophagosomal phagophore in yeast Saccharomyces cerevisiae. Mol. Biol. Cell. 21, 2270– 2284 (2010). 20444982 PMC2893990
  11. Yen W. L. et al. The conserved oligomeric Golgi complex is involved in double-membrane vesicle formation during autophagy. J. Cell Biol. 188, 101– 114 (2010). 20065092 PMC2812853
  12. Yla-Anttila P., Vihinen H., Jokitalo E. & Eskelinen E. L. 3D tomography reveals connections between the phagophore and endoplasmic reticulum. Autophagy 5, 1180– 1185 (2009). 19855179
  13. Moreau K., Ravikumar B., Renna M., Puri C. & Rubinsztein D. C. Autophagosome precursor maturation requires homotypic fusion. Cell 146, 303– 317 (2011). 21784250 PMC3171170
  14. Knaevelsrud H. et al. Membrane remodeling by the PX-BAR protein SNX18 promotes autophagosome formation. J. Cell Biol. 202, 331– 349 (2013). 23878278 PMC3718966
  15. Puri C., Renna M., Bento C. F., Moreau K. & Rubinsztein D. C. Diverse autophagosome membrane sources coalesce in recycling endosomes. Cell 154, 1285– 1299 (2013). 24034251 PMC3791395
  16. Furuta N., Fujita N., Noda T., Yoshimori T. & Amano A. Combinational soluble N-ethylmaleimide-sensitive factor attachment protein receptor proteins VAMP8 and Vti1b mediate fusion of antimicrobial and canonical autophagosomes with lysosomes. Mol. Biol. Cell 21, 1001– 1010 (2010). 20089838 PMC2836953
  17. Jun G. et al. Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch. Neurol. 67, 1473– 1484 (2010). 20697030 PMC3048805
  18. Hollingworth P. et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease. Nat. Genet. 43, 429– 435 (2011). 21460840 PMC3084173
  19. Lambert J. C. et al. Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations. Neurobiol. Aging 32, 756 e11– 5 (2011). 21220176
  20. Schjeide B. M. et al. The role of clusterin, complement receptor 1, and phosphatidylinositol binding clathrin assembly protein in Alzheimer disease risk and cerebrospinal fluid biomarker levels. Arch. Gen. Psychiatry 68, 207– 213 (2011). 21300948
  21. Ando K. et al. Clathrin adaptor CALM/PICALM is associated with neurofibrillary tangles and is cleaved in Alzheimer's brains. Acta Neuropathol. 125, 861– 878 (2013). 23589030
  22. Harel A., Wu F., Mattson M. P., Morris C. M. & Yao P. J. Evidence for CALM in directing VAMP2 trafficking. Traffic 9, 417– 429 (2008). 18182011
  23. Miller S. E. et al. The molecular basis for the endocytosis of small R-SNAREs by the clathrin adaptor CALM. Cell 147, 1118– 1131 (2011). 22118466 PMC3267021
  24. Rubinsztein D. C. et al. In search of an “autophagomometer”. Autophagy 5, 585– 589 (2009). 19411822
  25. Tebar F., Bohlander S. K. & Sorkin A. Clathrin assembly lymphoid myeloid leukemia (CALM) protein: localization in endocytic-coated pits, interactions with clathrin, and the impact of overexpression on clathrin-mediated traffic. Mol. Biol. Cell 10, 2687– 2702 (1999). 10436022 PMC25500
  26. Meyerholz A. et al. Effect of clathrin assembly lymphoid myeloid leukemia protein depletion on clathrin coat formation. Traffic 6, 1225– 1234 (2005). 16262731
  27. Suzuki M. et al. The clathrin assembly protein PICALM is required for erythroid maturation and transferrin internalization in mice. PLoS One 7, e31854 (2012). 22363754 PMC3283694
  28. Sahlender D. A., Kozik P., Miller S. E., Peden A. A. & Robinson M. S. Uncoupling the functions of CALM in VAMP sorting and clathrin-coated pit formation. PLoS One 8, e64514 (2013). 23741335 PMC3669311
  29. Maritzen T., Koo S. J. & Haucke V. Turning CALM into excitement: AP180 and CALM in endocytosis and disease. Biol. Cell 104, 588– 602 (2012). 22639918
  30. Narain Y., Wyttenbach A., Rankin J., Furlong R. A. & Rubinsztein D. C. A molecular investigation of true dominance in Huntington's disease. J. Med. Genet. 36, 739– 746 (1999). 10528852 PMC1734229
  31. Fujita N. et al. An Atg4B mutant hampers the lipidation of LC3 paralogues and causes defects in autophagosome closure. Mol. Biol. Cell 19, 4651– 4659 (2008). 18768752 PMC2575160
  32. Belaid A. et al. Autophagy and SQSTM1 on the RHOA(d) again: emerging roles of autophagy in the degradation of signaling proteins. Autophagy 10, 201– 208 (2014). 24300375 PMC5396087
  33. Dietzl G. et al. A genome-wide transgenic RNAi library for conditional gene inactivation in Drosophila. Nature 448, 151– 156 (2007). 17625558
  34. Zhang B. et al. Synaptic vesicle size and number are regulated by a clathrin adaptor protein required for endocytosis. Neuron 21, 1465– 1475 (1998). 9883738
  35. Simonsen A. et al. Promoting basal levels of autophagy in the nervous system enhances longevity and oxidant resistance in adult Drosophila. Autophagy 4, 176– 184 (2008). 18059160
  36. Wittmann C. W. et al. Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science 293, 711– 714 (2001). 11408621
  37. Goedert M., Spillantini M. G., Cairns N. J. & Crowther R. A. Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron 8, 159– 168 (1992). 1530909
  38. Suri C., Fung B. P., Tischler A. S. & Chikaraishi D. M. Catecholaminergic cell lines from the brain and adrenal glands of tyrosine hydroxylase-SV40 T antigen transgenic mice. J. Neurosci. 13, 1280– 1291 (1993). 7680068 PMC6576599
  39. Scotland P. B. et al. The PICALM protein plays a key role in iron homeostasis and cell proliferation. PLoS One 7, e44252 (2012). 22952941 PMC3431333
  40. Richet E. et al. NUB1 modulation of GSK3beta reduces tau aggregation. Hum. Mol. Genet. 21, 5254– 5267 (2012). 22965877
  41. Cadwell K. et al. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 456, 259– 263 (2008). 18849966 PMC2695978
  42. Mizushima N. et al. A protein conjugation system essential for autophagy. Nature 395, 395– 398 (1998). 9759731
  43. Jahreiss L., Renna M., Bittman R., Arthur G. & Rubinsztein D. C. 1-O-Hexadecyl-2-O-methyl-3-O-(2'-acetamido-2'-deoxy-beta-D-glucopyranosyl) -sn-glycerol (Gln) induces cell death with more autophagosomes which is autophagy-independent. Autophagy 5, 835– 846 (2009). 19550143
  44. Puri C. Loss of myosin VI no insert isoform (NoI) induces a defect in clathrin-mediated endocytosis and leads to caveolar endocytosis of transferrin receptor. J. Biol. Chem. 284, 34998– 35014 (2009). 19840950 PMC2787362
  45. Zavodszky E. et al. Mutation in VPS35 associated with Parkinson's disease impairs WASH complex association and inhibits autophagy. Nat. Commun. 5, 3828 (2014). 24819384 PMC4024763
  46. Kimmel C. B., Ballard W. W., Kimmel S. R., Ullmann B. & Schilling T. F. Stages of embryonic development of the zebrafish. Dev. Dyn. 203, 253– 310 (1995). 8589427
  47. Utton M. A. et al. The slow axonal transport of the microtubule-associated protein tau and the transport rates of different isoforms and mutants in cultured neurons. J. Neurosci. 22, 6394– 6400 (2002). 12151518 PMC6758152
  48. Kennedy B. N., Vihtelic T. S., Checkley L., Vaughan K. T. & Hyde D. R. Isolation of a zebrafish rod opsin promoter to generate a transgenic zebrafish line expressing enhanced green fluorescent protein in rod photoreceptors. J. Biol. Chem. 276, 14037– 14043 (2001). 11278688
  49. Cerda G. A., Thomas J. E., Allende M. L., Karlstrom R. O. & Palma V. Electroporation of DNA, RNA, and morpholinos into zebrafish embryos. Methods 39, 207– 211 (2006). 16837210
  50. Williams J. A. et al. Programmed cell death in zebrafish rohon beard neurons is influenced by TrkC1/NT-3 signaling. Dev. Biol. 226, 220– 230 (2000). 11023682
  51. Guntern R., Bouras C., Hof P. R. & Vallet P. G. An improved thioflavine S method for staining neurofibrillary tangles and senile plaques in Alzheimer's disease. Experientia 48, 8– 10 (1992). 1371102
  52. Bischof J., Maeda R. K., Hediger M., Karch F. & Basler K. An optimized transgenesis system for Drosophila using germ-line-specific phiC31 integrases. Proc. Natl Acad. Sci. USA 104, 3312– 3317 (2007). 17360644 PMC1805588
  53. Nagy P. et al. Atg17/FIP200 localizes to perilysosomal Ref(2)P aggregates and promotes autophagy by activation of Atg1 in Drosophila. Autophagy 10, 453– 467 (2014). 24419107 PMC4077884
  54. Lee T. & Luo L. Mosaic analysis with a repressible cell marker for studies of gene function in neuronal morphogenesis. Neuron 22, 451– 461 (1999). 10197526
  55. Freeman M. Reiterative use of the EGF receptor triggers differentiation of all cell types in the Drosophila eye. Cell 87, 651– 660 (1996). 8929534
  56. Hazelett D. J., Bourouis M., Walldorf U. & Treisman J. E. decapentaplegic and wingless are regulated by eyes absent and eyegone and interact to direct the pattern of retinal differentiation in the eye disc. Development 125, 3741– 3751 (1998). 9716539
  57. Lin D. M. & Goodman C. S. Ectopic and increased expression of Fasciclin II alters motoneuron growth cone guidance. Neuron 13, 507– 523 (1994). 7917288
  58. Parkes T. L. et al. Extension of Drosophila lifespan by overexpression of human SOD1 in motorneurons. Nat. Genet. 19, 171– 174 (1998). 9620775
  59. Park D., Veenstra J. A., Park J. H. & Taghert P. H. Mapping peptidergic cells in Drosophila: where DIMM fits in. PLoS One 3, e1896 (2008). 18365028 PMC2266995
  60. Green E. W., Fedele G., Giorgini F. & Kyriacou C. P. A Drosophila RNAi collection is subject to dominant phenotypic effects. Nat. Methods 11, 222– 223 (2014). 24577271

Cited by

Sorted by citations

Authors
Moreau, K., Fleming, A., Imarisio, S., Lopez Ramirez, A., Mercer, J. L., Jimenez-Sanchez, M., Bento, C. F., Puri, C., Zavodszky, E., Siddiqi, F., Lavau, C. P., Betton, M., O’Kane, C. J., Wechsler, D. S., & Rubinsztein, D. C.
Affiliations
  • University of Cambridge (GB)
  • Duke University (US)
  • Duke Medical Center (US)
Corresponding author
Rubinsztein, David C.
Venue
Nature Communications
Published
2014-09-22
Volume
5
Issue
1
Pages
4998-4998
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2142222850
Cited by
281
References
6
Citations by year
2026: 14 · 2025: 21 · 2024: 23 · 2023: 13 · 2022: 26 · 2021: 36 · 2020: 42 · 2019: 26 · 2018: 20 · 2017: 21 · 2016: 24 · 2015: 11 · 2014: 3 · 2013: 1
FWCI
13.11
Type
journal article
Language
en
Open access
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (publishedVersion, other-oa)
  • DIGITAL.CSIC (Spanish National Research Council (CSIC)) (acceptedVersion, other-oa)
  • RePEc: Research Papers in Economics (submittedVersion)
  • Apollo (University of Cambridge) (submittedVersion, cc-by)
Funders
  • Wellcome Trust (109281, 100140, 089703, 095317)
  • University of Cambridge
  • Universidad de Granada
  • Tau Consortium
  • Medical Research Council (MC_G1000734)
  • Cambridge Institute for Medical Research, University of Cambridge
  • Research Institute for Microbial Diseases, Osaka University
  • National Cancer Institute (R01CA109281)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
Keywords
PICALM, CALM, Alzheimer's disease, autophagy, tau accumulation, tau clearance, SNARE proteins, VAMP2, VAMP3, VAMP8, endocytosis, autophagosome formation, autophagosome degradation, genetic susceptibility loci
MeSH terms
Autophagy-Related Protein 12, Animals, Autophagy, Cell Line, Drosophila, Endocytosis, Female, Fibroblasts, HeLa Cells, Humans, Male, Phagosomes, Protein Binding, Risk Factors, Transfection, Zebrafish, tau Proteins, Small Ubiquitin-Related Modifier Proteins, Monomeric Clathrin Assembly Proteins, RNA, Small Interfering, Vesicle-Associated Membrane Protein 2, Mice, Genome-Wide Association Study, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review